Thalidomide

Common brands: Thalomid, Ozurdex, Dexamethasone, Dexamethasone 1.5 Mg, Dextenza

Top reporter: Celgene Corporation

Corticosteroid [EPC]Proteasome Inhibitor [EPC]Alkylating Drug [EPC]Thalidomide Analog [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]
36,316
Total Reports
16,889
Serious Reports
12,145
Death Reports
30
Reported Reactions
Death Report Ratio: High (33.44%)

Patient Demographics

Male
18,391
Female
14,240

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Thalidomide.

# Reaction Reports % of Total
1 DEATH 6,402
17.5%
2 DISEASE PROGRESSION 2,490
6.8%
3 PLASMA CELL MYELOMA 2,006
5.5%
4 NEUROPATHY PERIPHERAL 1,819
5.0%
5 OFF LABEL USE 1,722
4.7%
6 PNEUMONIA 1,711
4.7%
7 FATIGUE 1,404
3.8%
8 DRUG INEFFECTIVE 1,134
3.1%
9 ANAEMIA 1,023
2.8%
10 ASTHENIA 1,021
2.8%
11 CONSTIPATION 995
2.7%
12 DYSPNOEA 988
2.7%
13 PYREXIA 957
2.6%
14 THROMBOCYTOPENIA 879
2.4%
15 NAUSEA 862
2.4%
16 MULTIPLE MYELOMA 856
2.3%
17 MALIGNANT NEOPLASM PROGRESSION 853
2.3%
18 DEEP VEIN THROMBOSIS 840
2.3%
19 NEUTROPENIA 832
2.3%
20 DIARRHOEA 830
2.3%
21 SEPSIS 815
2.2%
22 RENAL FAILURE 781
2.1%
23 INFECTION 780
2.1%
24 DIZZINESS 755
2.1%
25 RASH 678
1.9%
26 FALL 655
1.8%
27 PULMONARY EMBOLISM 655
1.8%
28 PAIN 605
1.7%
29 VOMITING 604
1.7%
30 OEDEMA PERIPHERAL 586
1.6%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.